Skip to main content

New method of measuring tumour infiltrating lymphocytes predicts long term outcomes for a type of early breast cancer

Researchers from Queen Mary University London and Emory University used a novel AI-based analytic tool to better understand how tumour infiltrating lymphocytes (TILs) can predict which cases of Ductal Carcinoma in Situ (DCIS) would go on to become invasive breast cancer.

Published on:
Back to top